Omeros Corporation — Quarterly Financial Statistics (NASDAQ:OMER) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 32.03 M28.98 M35.8 M22 M18.5 M 105.28 M Cash from investing activities 36.04 M34.95 M38.54 M21.3 M-6.86 M 87.93 M Cash from financing activities -4.58 M-4.09 M1.84 M1.72 M18.71 M 18.18 M Free cash flow 32.03 M28.95 M35.76 M21.99 M18.49 M 105.19 M

Haberler

Omeros hisseleri ilk YARTEMLEA ticari sevkiyatlarının başlamasıyla yükseldi

Omeros stock rises as first commercial YARTEMLEA shipments begin

Omeros begins commercial distribution of TA-TMA treatment Yartemlea

Omeros VP Borges sells $750k in shares

Omeros Corporation (OMER) Discusses FDA Approval and Commercialization Plans for YARTEMLEA in TA-TMA Treatment Transcript

Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA

Omeros: Why The Novo Nordisk Deal Is More Important Than FDA Approval (NASDAQ:OMER)

Biohaven, Omeros And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Andersen Group (NYSE:ANDG), Biohaven (NYSE:BHVN)

Why Davis Commodities Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - AlphaTON Capital (NASDAQ:ATON), Biohaven (NYSE:BHVN)

NKE, OMER, MU, INTC, DVAX: 5 Trending Stocks Today - Nike (NYSE:NKE)

Omeros: Stock Pops On Yartemlea Approval, Longer-Term Upside Likely (NASDAQ:OMER)

Micron Tech and Nike among market cap stock movers on Wednesday